Ansa Biotechnologies, Inc.

We love this piece from Genetic Engineering & Biotechnology News rounding up the latest #DNAsynthesis innovations, with a peek at how Ansa's technology is making a difference for scientists with a unique technology that can produce #complexDNA. https://lnkd.in/g4YQwt3g

⚡What was the lightning strikes, once-in-a-career idea that launched Ansa? A unique #DNAsynthesis technique that works with enzymes to create long, complex oligonucleotides. Ansa founders Daniel Lin-Arlow and Sebastian Palluk are featured in this dive into enzymatic DNA synthesis by The Scientist. Read on to learn more about how chemical approaches for synthesizing DNA oligonucleotides are being replaced by enzymatic methods, which can generate longer strands, such as gene fragments, with a lower error rate, without damaging DNA: https://lnkd.in/eKXbaE42 #SyntheticDNA #Ansamers #synbio #longDNA #biotech #DNAInnovation #complexDNA  #customDNA #EnzymaticDNA

June is more than just liberating your summer wardrobe and planning the first BBQ of the season. It's also a time of celebration, remembrance and intersectional allyship. We celebrate two major identities during the month of June: the #LGBTQIA+ and Black communities. 🏳️🌈 #PRIDEmonth honors and celebrates the struggle and triumph of the LGBTQIA+ community 💪🏾 #Juneteenth, or “Freedom Day” commemorates the announcement of the Emancipation Proclamation in Texas, two years after the Emancipation Proclamation became law. In order to celebrate with integrity this June, here are some excellent resources compiled by Alexis BralyJames of Construct The Present (Certified B corp) (a must-follow site for all business leaders committed to fostering an inclusive workplace): https://lnkd.in/ezmsNPmJ May your month be full of reflection, connection, celebration, and growth! #business #leadership #science #DEI #diversityandinclusion #employeeempowerment #EquityInSTEM

🧬 Faced with the challenge to reliably synthesize and produce complex plasmid DNAs used in the production of viral vectors for gene therapy, Novel Biotechnology submitted 51 UTR sequences for complexity screening to three commonly used DNA synthesis vendors, as well as to Ansa. As they reported in this poster, the majority of the sequences were rejected outright by most vendors, but 100% were accepted for synthesis by Ansa. "Here we have shown how innovations in DNA synthesis and assembly enable the routine production of plasmid designs that would have been difficult, if not impossible, to generate using conventional techniques. These innovations include the use of Ansa’s enzymatic DNA synthesis platform in conjunction with Novel Bio’s in-house workflows for plasmid DNA production. The use of these technologies enabled us to seamlessly deliver on a complicated gene therapy project. Without this capability, this project would have become considerably more complex and costly." Thanks for sharing this success story, Novel Biotechnology Inc.! Interested in putting our #complexDNA synthesis services to the test on your project? Learn how to join our Early Access Program: https://lnkd.in/grMhxgfN #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

What a fantastic #SynBioBeta2024! Thanks to all who attended our talks, stopped by the booth, or joined us for drinks! A special shout out to John Cumbers and the SynBioBeta crew, as well as our amazing early access customers who shared their insights, Olga Bielska, Greg Lohman, Jaymin Patel and Tae Seok Moon. In case you missed our big news at the event, visit https://lnkd.in/grMhxgfN to learn about our expanded Early Access Program. We're excited to work with you to make the impossible possible with complex #DNAsynthesis. #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

We spy Ansa CEO Jason T. Gammack in this #SynBioBeta highlights reel! Thanks for sharing, SynBioBeta, and for organizing such a fun event!

What a fantastic start to #SynBioBeta2024! Thanks to all who attended our talks yesterday, and to our amazing early access customers, Olga Bielska, Greg Lohman, Jaymin Patel, and Tae Seok Moon, who shared their incredible insights! In case you missed any of it, stop by our booth (312) for some pop-up talks, and join us tonight for some celebratory drinks. 🍸 Cocktail mixer 🍹 🗓️ Wednesday, May 8 ⌚ 7-8:30 pm PDT 📍Market Street Room #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

Our final #SynBioBeta2024 panel of the day is a good one! Hear from some of our early access customers about how they are able to explore new avenues of science with complex DNA constructs. Happening soon! Embrace Complexity: Insights from Ansa’s DNA Synthesis Early Access Partners 📍210B Breakout session  🗓️ Tuesday, May 7 ⌚ 2:45 pm PDT ·         Olga Bielska, PhD, Buck Institute for Research on Aging ·         Greg Lohman, PhD, New England Biolabs ·         Jaymin Patel, PhD, University of California, Berkeley ·         Tae Seok Moon, PhD, J. Craig Venter Institute #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

That was a great panel discussion! There are some significant macro trends in the synthesis market, such as the importance of longer oligos, the ability to synthesize complex sequences, and the commitment to fulfill all constructs in every order, every time, and on time. I'm pleased that the Ansa Biotechnologies, Inc. team is driving innovation and development efforts to advance these critical metrics further.

Jason T. Gammack from Ansa Biotechnologies, Inc. dives into unlocking that dream experiment by talking about re-engineering the DNA synthesis process and overcoming the constraints of legacy tech. Ansa can provide 600 bp products to allow users access to complex sequences. #synbiobeta2024